Filing Flows › CareDx (CDNA) › Q2 2026 › vs Q2 2025
CareDx (CDNA) Q2 2026 vs Q2 2025 (year over year)
CareDx's revenue rose $45.3M (+52%) from $86.7M in Q2 2025 to $132M in Q2 2026. The biggest changes: Testing services revenue +$37.9M (+61%); Patient and digital solutions revenue +$6.4M (+50%); Product revenue +$958K (+8%). Operating margin 85.8% against -12.8% (+98.6 pts).
CareDx, Q2 2026: revenue $132M (+52% year over year), operating margin 85.8%, net earnings $111M, operating cash flow $30.6M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 85.8% | -12.8% | +98.6 pts |
| Net margin | 83.8% | -9.9% | +93.7 pts |
| Free cash flow margin | 21.8% | 10.3% | +11.5 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Testing services revenue | $99.9M | $62.0M | $37.9M | +61% |
| Patient and digital solutions revenue | $19.2M | $12.8M | $6.4M | +50% |
| Product revenue | $12.8M | $11.8M | $958K | +8% |
| Revenue | $132M | $86.7M | $45.3M | +52% |
| Other income, net | $1.3M | $2.4M | −$1.1M | -47% |
| Operating profit | $113M | −$11.1M | $124M | — |
| Costs & expenses | $18.7M | $97.8M | −$79.1M | -81% |
| Pre-tax earnings | $115M | −$8.7M | $123M | — |
| Net earnings | $111M | −$8.6M | $119M | — |
| Income tax | $3.9M | −$117K | $4.0M | — |
| Depreciation & amortization | $2.8M | $3.7M | −$911K | -24% |
| Share-based compensation | $10.7M | $9.4M | $1.2M | +13% |
| Working capital & other | $93.5M | −$5.3M | $98.8M | — |
| Operating cash flow | $30.6M | $9.9M | $20.7M | +209% |
| Free cash flow (OCF − capex) | $28.7M | $8.9M | $19.9M | +223% |
| Capital expenditures | $1.9M | $1.0M | $851K | +85% |
Questions
How much did CareDx's revenue grow year over year in Q2 2026?
CareDx's revenue rose $45.3M (+52%) from $86.7M in Q2 2025 to $132M in Q2 2026.
What drove CareDx's revenue change in Q2 2026?
Testing services revenue +$37.9M (+61%); Patient and digital solutions revenue +$6.4M (+50%); Product revenue +$958K (+8%).